Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Pulmonary Hypertension

Free Subscription 02.11.2026 1 Am J Physiol Heart Circ Physiol 1 Am J Respir Cell Mol Biol 1 Am J Respir Crit Care Med 1 Anatol J Cardiol 1 Animal Model Exp Med 1 Animals (Basel) 1 Ann Am Thorac Soc 1 Biomolecules 1 Bull Exp Biol Med 1 Can Respir J 1 Cells 1 Circ Res 5 Circulation 1 CJC Pediatr Congenit Heart Dis 1 Cureus 1 Eur J Pediatr 1 Eur J Pharmacol 1 Front Immunol 2 Front Med (Lausanne) 1 Front Pediatr 3 Int J Mol Sci 1 J Am Heart Assoc 1 J Hypertens 1 JACC Cardiovasc Interv 1 JACC Heart Fail 1 JAMA Cardiol 2 JTCVS Open 1 Med Sci (Basel) 1 Open Respir Arch 1 Pediatr Pulmonol 1 Pharmaceuticals (Basel) 1 Planta Med 5 Pulm Circ 1 Radiol Cardiothorac Imaging 1 Radiother Oncol 1 Redox Biol 1 Respir Physiol Neurobiol 1 Tissue Cell 1 Zhonghua Yi Xue Za Zhi

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Physiol Heart Circ Physiol

1. PALACIOS-ECHAVARREN C, Lizarrondo EPEM, Rodriguez-Arias JJ, Ayala B, et al
   Right Ventricular Afterload Across the Pulmonary Hypertension Spectrum.
   Am J Physiol Heart Circ Physiol. 2026 Oct 21. doi: 10.1152/ajpheart.90205.2026.
   PubMed         Abstract available
   
   

   
   Am J Respir Cell Mol Biol

2. BOUSSEAU S, Frump AL, Walts A, Sobrano Fais R, et al
   17beta-Estradiol and Estrogen Receptor alpha Promote Right Ventricle Angiogenesis in Pulmonary Hypertension via Apelin Signaling.
   Am J Respir Cell Mol Biol. 2026 Oct 29:aanag177. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Am J Respir Crit Care Med

3. WANG J, Feng Y, Shen Y, Gan X, et al
   Therapeutic Targeting of the Macrophage YTHDC1/TIGAR/NF-kappaB Axis Mitigates Pulmonary Hypertension.
   Am J Respir Crit Care Med. 2026 Oct 26:aamag496. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Anatol J Cardiol

4. KILICKIRAN AVCI B, Akbulut M, Akdogan A, Atas H, et al
   Joint Expert Consensus Report on the Diagnosis and Management of Pulmonary Arterial Hypertension in Turkiye In collaboration with Turkish Society of Cardiology, Turkish Thoracic Society and Pulmonary Vascular Disease Research Association (ADHAD).
   Anatol J Cardiol. 2026;30:722-739.
   PubMed         Abstract available
   
   

   
   Animal Model Exp Med

5. YEGEN CH, Maakoul Z, Marchant D, Callard P, et al
   Repeated instillations of bleomycin in male mice induce a perivascular remodeling at distance of fibrotic areas in the context of progressive pulmonary fibrosis.
   Animal Model Exp Med. 2026;9:1956-1963.
   PubMed         Abstract available
   
   

   
   Animals (Basel)

6. MATOS JI, Diaz-Rocio C, Garcia-Rodriguez SN, Caro-Vadillo A, et al
   Diagnostic Value of the Vertebral Right Heart Index (VRHi) for Identifying Pulmonary Hypertension in Dogs with Heartworm Disease.
   Animals (Basel). 2026;16:3239.
   PubMed         Abstract available
   
   

   
   Ann Am Thorac Soc

7. CIRULIS MM, Auger WR, Benza RL, Channick RN, et al
   Biological sex differences in the United States CTEPH Registry.
   Ann Am Thorac Soc. 2026;23:1640-1651.
   PubMed         Abstract available
   
   

   
   Biomolecules

8. AYIK S, Huz M, Ulutas Z, Balkar ME, et al
   alpha-Lipoic Acid, with or Without Ambrisentan, Attenuates Experimental Pulmonary Arterial Hypertension: Associations with AMPK/mTOR/NF-kappaB Signaling and Kallistatin.
   Biomolecules. 2026;16:1432.
   PubMed         Abstract available
   
   

   
   Bull Exp Biol Med

9. ABRAMOV AA, Bobylev AG, Vikhlyantsev IM, Lakomkin VL, et al
   Transcriptomic Features of Thyroid Signaling Disorders in Experimental Pulmonary Arterial Hypertension.
   Bull Exp Biol Med. 2026;181:177-185.
   PubMed         Abstract available
   
   

   
   Can Respir J

10. 
    Correction to "The Diagnostic Value of Transthoracic Echocardiography Parameters Under the New Diagnostic Criteria for Pulmonary Hypertension".
    Can Respir J. 2026;2026:9809063.
    PubMed        
    
    

    
    Cells

11. ZHAN S, Deng Y, Chen P, Lv T, et al
    Tirzepatide Attenuates Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension: Association with the SIRT1/H4K12la/c-Jun Axis.
    Cells. 2026;15:1900.
    PubMed         Abstract available
    
    

    
    Circ Res

12. GILLAN JL, Kamp J, Kucherenko MM, Winkler A, et al
    CCR2-Dependent Myeloid Cell Recruitment Links Post-MI Heart Failure to Pulmonary Hypertension.
    Circ Res. 2026 Oct 26. doi: 10.1161/CIRCRESAHA.126.329553.
    PubMed         Abstract available
    
    

    
    Circulation

13. YUAN X, Pan K, He S
    Letter by Yuan et al Regarding Article, "Breast Cancer Reveals Latent BMPR2-Related Susceptibility to Pulmonary Hypertension".
    Circulation. 2026;154:e655-e656.
    PubMed        
    
    
14. PACKER M, Gomberg-Maitland M, Tedford RJ, Langleben D, et al
    Effect of Activin Type II Receptor Signaling in Patients With HFpEF and Pulmonary Hypertension: A Critical Analysis of Biological Mechanisms and Clinical Trials.
    Circulation. 2026;154:1739-1749.
    PubMed         Abstract available
    
    
15. DENG W, Chen Y
    Letter by Deng and Chen Regarding Article, "Breast Cancer Reveals Latent BMPR2-Related Susceptibility to Pulmonary Hypertension".
    Circulation. 2026;154:e659-e660.
    PubMed        
    
    
16. MOUGIN M, Jambon-Barbara C, Boucherat O, Provencher S, et al
    Response by Mougin et al to Letter Regarding Article, "Breast Cancer Reveals Latent BMPR2-Related Susceptibility to Pulmonary Hypertension".
    Circulation. 2026;154:e661-e662.
    PubMed        
    
    
17. SHUI W, Chen Z, Lan C
    Letter by Shui et al Regarding Article, "Breast Cancer Reveals Latent BMPR2-Related Susceptibility to Pulmonary Hypertension".
    Circulation. 2026;154:e657-e658.
    PubMed        
    
    

    
    CJC Pediatr Congenit Heart Dis

18. ALBERTINI M, David P, Nougue H, Cholley B, et al
    Atrial Flow Regulator Bridging to Heart Transplantation in Congenital Heart Disease With Severe Combined Pulmonary Hypertension.
    CJC Pediatr Congenit Heart Dis. 2026;5:341-344.
    PubMed        
    
    

    
    Cureus

19. STRAKA K, Polymerou I, Christakou E
    Severe Pulmonary Hypertension in Critically Ill Children: A 10-Year Single-Center Case Series and Practical Management Considerations.
    Cureus. 2026;18:e116689.
    PubMed         Abstract available
    
    

    
    Eur J Pediatr

20. YOO K, Kim SH, Park J, Kim TG, et al
    Early echocardiographic hemodynamic phenotypes and clinical outcomes in congenital diaphragmatic hernia.
    Eur J Pediatr. 2026;185:897.
    PubMed         Abstract available
    
    

    
    Eur J Pharmacol

21. TANG Y, Shi Y, Wang M, Cai S, et al
    Stigmasterol Ameliorates Pulmonary Hypertension by Suppressing the CCL5/CCR5 Signaling Pathway: Taurocholic Acid as a Downstream Mediator.
    Eur J Pharmacol. 2026 Oct 29:179492. doi: 10.1016/j.ejphar.2026.179492.
    PubMed         Abstract available
    
    

    
    Front Immunol

22. CHEN X, Wu W, Liu Y, Lian G, et al
    Integrative single-cell and bulk transcriptomic analysis identifies monocyte/macrophage senescence-associated candidate genes in pulmonary arterial hypertension.
    Front Immunol. 2026;17:1938985.
    PubMed         Abstract available
    
    

    
    Front Med (Lausanne)

23. YAN X, Xie L, Li H, Tang J, et al
    Pulmonary hypertension in a patient with HHV-8-negative multicentric castleman disease and epstein-barr virus co-infection: a case report.
    Front Med (Lausanne). 2026;13:1951176.
    PubMed         Abstract available
    
    
24. XIA Y, Yang Y, Yang J
    Development and multi-database validation of machine learning models for 28-day mortality prediction in ICU patients with COPD and pulmonary hypertension.
    Front Med (Lausanne). 2026;13:1959885.
    PubMed         Abstract available
    
    

    
    Front Pediatr

25. LIU Y, Yuan D, Lv Y, Huang B, et al
    Case Report: Neonatal ultra-severe hemolytic anemia complicated by pulmonary hypertension induced by compound heterozygous variants in the KLF1 gene and literature review.
    Front Pediatr. 2026;14:1943478.
    PubMed         Abstract available
    
    

    
    Int J Mol Sci

26. BOSACOMA A, Garcia AR, Madrigal I, Lozano JJ, et al
    Targeted DNA Sequencing Reveals Distinct Rare-Variant Profiles in Pulmonary Hypertension Associated with Chronic Lung Diseases.
    Int J Mol Sci. 2026;27:8992.
    PubMed         Abstract available
    
    
27. MORENO-CACERES S, Marciano DP
    Endothelial Redox Dysregulation in Pulmonary Arterial Hypertension: Compartmentalized Mechanisms and Therapeutic Implications.
    Int J Mol Sci. 2026;27:9096.
    PubMed         Abstract available
    
    
28. OLIVEIRA FP, Menezes TCF, Mickael C, Oliveira RKF, et al
    The Functional Molecular Biopsy: Exercise-Induced Transpulmonary Multi-Omic Profiling in Pulmonary Arterial Hypertension.
    Int J Mol Sci. 2026;27:9130.
    PubMed         Abstract available
    
    

    
    J Am Heart Assoc

29. LI Y, Zhu T, Lin D, Cao C, et al
    Thioredoxin-Interacting Protein-Regulated in Development and DNA Damage-Response 1-Driven Macrophage Senescence Promotes Hypoxia-Induced Pulmonary Hypertension.
    J Am Heart Assoc. 2026 Oct 23:e049236. doi: 10.1161/JAHA.126.049236.
    PubMed         Abstract available
    
    

    
    J Hypertens

30. ZOCCALI C, Sarnak MJ, Kanbay M, Rotmans JI, et al
    Pulmonary hypertension and right ventricular dysfunction in hemodialysis: an overlooked cardiorenal interface and a target for dialysis prescription.
    J Hypertens. 2026 Oct 20. doi: 10.1097/HJH.0000000000004478.
    PubMed         Abstract available
    
    

    
    JACC Cardiovasc Interv

31. MIYAMOTO J, Ohno Y, Noda S, Kamioka N, et al
    Periprocedural Pulmonary Hypertension and Outcomes After Mitral Valve Transcatheter Edge-to-Edge Repair.
    JACC Cardiovasc Interv. 2026;19:2726-2739.
    PubMed         Abstract available
    
    

    
    JACC Heart Fail

32. AIREWELE E, Ali A, Cajigas H, Ramani M, et al
    Pulmonary Hypertension and Its Association With Cardiac Transplant Outcomes: Does Pulmonary Artery Systolic Pressure Matter?
    JACC Heart Fail. 2026 Oct 27:103480. doi: 10.1016/j.jchf.2026.103480.
    PubMed        
    
    

    
    JAMA Cardiol

33. YOGESWARAN A, Berger M, De Bie E, Kiely DG, et al
    Systemic Hypertension and Survival in Pulmonary Hypertension.
    JAMA Cardiol. 2026 Oct 30. doi: 10.1001/jamacardio.2026.4834.
    PubMed         Abstract available
    
    

    
    JTCVS Open

34. ALAMRI R, Majeed H, Ahmad F, Sarfaraz Z, et al
    Evaluating preoperative imaging in patients with chronic thromboembolic pulmonary hypertension: Is computed tomography pulmonary angiography a reliable alternative to pulmonary angiography?
    JTCVS Open. 2026;33:101960.
    PubMed         Abstract available
    
    
35. MERCIER O, Dedier L, Issard J, Savale L, et al
    Left atrial pressure continuous monitoring improves early postoperative outcomes after double-lung transplantation for pulmonary hypertension.
    JTCVS Open. 2026;33:101967.
    PubMed         Abstract available
    
    

    
    Med Sci (Basel)

36. ERAKY AM, Chazhikattu AJ, Crum JM, Simmons J, et al
    Physiology-Guided Management of Acute Right Ventricular Failure and Pulmonary Hypertension in Critically Ill Patients: Hemodynamic Phenotypes, Ventilator Interactions, and Rescue Strategies.
    Med Sci (Basel). 2026;14:694.
    PubMed         Abstract available
    
    

    
    Open Respir Arch

37. VARGAS-URSUA F, Cruz-Utrilla A, Tenes A
    Sotatercept as a Treatment for Pulmonary Hypertension Associated With Connective Tissue Disease and ILD.
    Open Respir Arch. 2026;8:100685.
    PubMed         Abstract available
    
    

    
    Pediatr Pulmonol

38. LILITWAT W
    When Two Wood Units Matter: From Measurement Bias to Clinical Reclassification in Pediatric Pulmonary Hypertension.
    Pediatr Pulmonol. 2026;61:e71891.
    PubMed        
    
    

    
    Pharmaceuticals (Basel)

39. ZHANG X, Xie J, Zhou Y, Gui W, et al
    Scutellarin Alleviates Pulmonary Hypertension by Inhibiting the NF-kappaB/NLRP3 Signaling Pathway to Suppress Inflammation and Pyroptosis.
    Pharmaceuticals (Basel). 2026;19:1595.
    PubMed         Abstract available
    
    

    
    Planta Med

40. HAN X, Zhang X, Zhang A, Meng Z, et al
    Integrating UHPLC-Q-TOF-MS/MS and Network Pharmacology to Reveal the Mechanism of Jinbei Oral Liquid in Radiation-Induced Lung Injury with Pulmonary Hypertension.
    Planta Med. 2026 Oct 30. doi: 10.1055/a-2993-4115.
    PubMed         Abstract available
    
    

    
    Pulm Circ

41. XU Z, Zhang M, Chen Y, Yu X, et al
    Salvage Use of Sotatercept for Potts Shunt in Refractory Pulmonary Hypertension.
    Pulm Circ. 2026;16:e70436.
    PubMed         Abstract available
    
    
42. NAQVI B, Bautista MA, Sanchez AP, Yang JZ, et al
    Chronic Thromboembolic Pulmonary Hypertension With Cold Agglutinins Needing Pulmonary Thromboendarterectomy: The Use of Therapeutic Plasma Exchange.
    Pulm Circ. 2026;16:e70423.
    PubMed         Abstract available
    
    
43. KHAN SL, Mathai SC
    Editorial on Submission "Beyond IPF: Pulmonary Function Test Predictors of Echocardiographic Pulmonary Hypertension Across the Spectrum of ILD.
    Pulm Circ. 2026;16:e70443.
    PubMed        
    
    
44. LI T, Zhang S, Aluquin V, Donnelly A, et al
    Early Tracheal and Salivary miRNAs in Extremely Preterm Infants Predict Bronchopulmonary Dysplasia-Related Pulmonary Hypertension.
    Pulm Circ. 2026;16:e70437.
    PubMed         Abstract available
    
    
45. KANAGARAJ UK, Saker A, Cuello-Garcia C, Castaldo M, et al
    Diuretics for Management of Bronchopulmonary Dysplasia Associated Pulmonary Hypertension in Preterm Infants-A Systematic Review.
    Pulm Circ. 2026;16:e70440.
    PubMed         Abstract available
    
    

    
    Radiol Cardiothorac Imaging

46. TAMIZUDDIN F, Fujikura K, Narula N, Stojanovska J, et al
    Pulmonary Hypertension: Clinical Classification Updates, Pathology, and Multimodality Imaging Evaluation.
    Radiol Cardiothorac Imaging. 2026;8:e260101.
    PubMed         Abstract available
    
    

    
    Radiother Oncol

47. BROWN KH, Ghita-Pettigrew M, McCabe L, McDowell MP, et al
    Photon FLASH spares radiation-induced lung injury and pulmonary hypertension in a preclinical model.
    Radiother Oncol. 2026;226:111822.
    PubMed         Abstract available
    
    

    
    Redox Biol

48. CHEN J, Chai M, Liu Y, Zhang Y, et al
    Inhibiting MD2 activates AMPK-dependent PPARgamma/NOX4 signaling to attenuate mitochondrial oxidative stress and relieve pulmonary hypertension.
    Redox Biol. 2026;98:104454.
    PubMed         Abstract available
    
    

    
    Respir Physiol Neurobiol

49. KOBAYASHI N, Droma Y, Ota M, Wada Y, et al
    Implications of genes involved in inflammatory regulation, cytoskeletal organization and extracellular matrix integrity for susceptibility to high-altitude pulmonary edema: A pilot whole-exome sequencing study.
    Respir Physiol Neurobiol. 2026;346:104658.
    PubMed         Abstract available
    
    

    
    Tissue Cell

50. JIANG J, Xu J, Wu T, Chen H, et al
    Smpd2 m(6)A modification contributes to hypoxic pulmonary hypertension via an alveolar epithelial cell senescence-associated phenotype.
    Tissue Cell. 2026;104.
    PubMed         Abstract available
    
    

    
    Zhonghua Yi Xue Za Zhi

51. 
    [Expert consensus on practice of echocardiography in adult pulmonary hypertension (2026 edition)].
    Zhonghua Yi Xue Za Zhi. 2026;106:4224-4251.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum